Journal List > J Korean Ophthalmol Soc > v.56(12) > 1010165

Han, Lee, and Chang: Etiological Analysis of Non Traumatic, Non Diabetic Spontaneous Vitreous Hemorrhage Using Vitrectomy

Abstract

Purpose

In this study we evaluated and analyzed the causes and prognosis of spontaneous vitreous hemorrhage except direct ocular trauma and diabetic retinopathy-induced vitreous hemorrhage confirmed after therapeutic vitrectomy.

Methods

The present study included Non-traumatic, non-diabetic vitreous hemorrhage patients who underwent vitrectomy in our hospital from March 2010 to December 2013 and were followed up for more than 1 year. Past history, preoperative visual acuity and intraocular pressure were evaluated postoperatively at 1, 3, 6 and 12 months.

Results

A total of 157 patients (157 eyes) were included in the study. Common causes of vitreous hemorrhage were branch reti-nal vein occlusion, retinal tear and age-related macular degeneration. Age-related macular degeneration and central retinal vein occlusion patients showed a poor visual prognosis. Lattice retinal degeneration or retinal tear in the opposite eye was observed in 27 patients and therefore, barrier laser was performed.

Conclusions

The most common cause of spontaneous vitreous hemorrhage was retinal vein occlusion. Visual prognosis varied depending on the cause of disease, but significant vision improvement can be expected if the macula is not involved. Additionally, in some patients without evidence of retinal detachment on ultrasound, a possible retinal tear accompanied by lo-calized retinal detachment should be considered.

References

1. Lindgren G, Lindblom B. Causes of vitreous hemorrhage. Curr Opin Ophthalmol. 1996; 7:13–9.
crossref
2. Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol. 1997; 42:3–39.
crossref
3. Isernhagen RD, Smiddy WE, Michels RG. . Vitrectomy for nondiabetic vitreous hemorrhage. Not associated with vascular disease. Retina. 1988; 8:81–7.
4. Verbraeken H, Van Egmond J. Non-diabetic and non-oculo-traumatic vitreous haemorrhage treated by pars plana vitrectomy. Bull Soc Belge Ophtalmol. 1999; 272:83–9.
5. Oyakawa RT, Michels RG, Blase WP. Vitrectomy for nondiabetic vitreous hemorrhage. Am J Ophthalmol. 1983; 96:517–25.
crossref
6. Davis MD. Natural history of retinal breaks without detachment. Arch Ophthalmol. 1974; 92:183–94.
crossref
7. Rabinowitz R, Yagev R, Shoham A, Lifshitz T. Comparison be-tween clinical and ultrasound findings in patients with vitreous hemorrhage. Eye (Lond). 2004; 18:253–6.
crossref
8. Moradian S, Valaee M, Ahmadieh H. . Outcomes of vitrectomy for non-traumatic non-diabetic vitreous hemorrhage. J Ophthalmic Vis Res. 2007; 2:46–51.
9. Moon JY, Park JS. Outcomes of vitrectomy for severe vitreous hemorrhage of unknown etiology. J Korean Ophthalmol Soc. 2014; 55:1024–9.
crossref
10. Singalavanija A, Tanterdtham J, Namatra C, Trinavarat A. Surgical management of nondiabetic vitreous hemorrhage. J Med Assoc Thai. 1999; 82:460–5.
11. Smiddy WE, Isernhagen RD, Michels RG. . Vitrectomy for nondiabetic vitreous hemorrhage. Retinal and choroidal vascular disorders. Retina. 1988; 8:88–95.
12. DiBernardo C, Blodi B, Byrne SF. Echographic evaluation of reti-nal tears in patients with spontaneous vitreous hemorrhage. Arch Ophthalmol. 1992; 110:511–4.
crossref
13. Shin KH, Nam DH, Lee DY. Comparison between retinal tear and rhegmatogenous retinal detachment as the cause of dense vitreous hemorrhage. J Korean Ophthalmol Soc. 2011; 52:448–53.
crossref
14. Kumar A, Verma L, Jha SN. . Ultrasonic errors in analysis of vitreous haemorrhage. Indian J Ophthalmol. 1990; 38:162–3.
15. Peyman GA, Schulman JA. Intravitreal Surgery, 2nd ed. New Orleans: Practice-Hall International Inc.,. 1994; 813–50.

Figure 1.
B-scan image of vitreous hemorrhage without retinal detachment.
jkos-56-1887f1.tif
Table 1.
Demographic characteristics and clinical features of the patients
Variables Data
Age (years) 63.9 ± 12.7
Range 9-89
Gender (male:female) 84:73
Previous medical history
Hypertension 93
Diabetus mellitus 36
Previous symptom duration (days) 39.6
Preoperative BCVA (log MAR) 1.83 ± 0.43
Preoperative IOP (mm Hg) 13.4 ± 4.23
Vitrectomy gauge (23 gauge:25 gauge) 95:62

Values are presented as mean ± SD unless otherwise indicated. SD = standard deviation; BCVA = best corrected visual acuity; IOP = intraocular pressure.

Table 2.
Cause of vitreous hemorrhage identified by vitrectomy
Age Cause of vitreous hemorrhage
Age Retinal tear BRVO CRVO AMD Macroaneurysm Eales Terson Angioma Unknown
0-9 1
10-19
20-29 2 1
30-39 1 1
40-49 2 3 3 1 1
50-59 11 22 1 4 2
60-69 9 19 3 5 1 3
70-79 6 20 3 13 2 1 5
80-89 6 4 1
Total 30 70 10 26 5 2 1 1 12
BRVO = bra nch retinal vein occlusion; CR RVO = centr ral retinal vein occlusion; AMD = age-related macular deg eneration.
Table 3.
Prognostic factors associated with postoperative 12-months visual acuity
Variables Preoperative BCVA Postoperative 12 months BCVA p-value*
(log MAR) (log MAR)
Macular state 0.043
Macular involve 1.79 ± 0.46 1.67 ± 0.47
Macular spare 1.59 ± 0.56 0.34 ± 0.52
Vitrectomy entry system 0.269
23 gauge 1.50 ± 0.61 0.58 ± 0.66
25 gauge 1.71 ± 0.45 0.66 ± 0.65
Vitreous cavity tamponade material 0.315
Air 1.53 ± 0.76 0.12 ± 0.18
C3 F8 1.45 ± 0.70 0.21 ± 0.17
SF6 1.03 ± 0.61 0.20 ± 0.17

Values are presented as mean ± SD unless otherwise indicated. BCVA = best corrected visual acuity *Chi-square test.

TOOLS
Similar articles